{
    "paper_id": "PMC3308597",
    "metadata": {
        "title": "Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines",
        "authors": [
            {
                "first": "Joyce",
                "middle": [],
                "last": "Hui-Yuen",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Shane",
                "middle": [],
                "last": "McAllister",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Siva",
                "middle": [],
                "last": "Koganti",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Erik",
                "middle": [],
                "last": "Hill",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Sumita",
                "middle": [],
                "last": "Bhaduri-McIntosh",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Note that Step 4, performed to predict successful outcome, is an optional step. If Step 4 is to be performed, you will need to incubate an additional flask of un-infected PBMC at 2 x 106 cells/ml as control.",
            "cite_spans": [],
            "section": "3. Infection with EBV ::: Protocol",
            "ref_spans": []
        },
        {
            "text": "Successful outcome is predicted by the presence of CD23hiCD58+ cells. Approximately 2-3% of live cells on day 3-4 after exposure to EBV should have this profile (Figure 2C). Other sub-populations of CD23+, CD23-, CD58+, and CD58- cells observed after exposure to EBV show minimal proliferation14. Un-infected cells (Figure 2A) and cells exposed to EBV from HH514-16 cells (Figure 2B), harboring a non-immortalizing strain of EBV, do not demonstrate CD23hiCD58+cells.",
            "cite_spans": [],
            "section": "6. Representative results: ::: Protocol",
            "ref_spans": []
        },
        {
            "text": "You may also visualize cells by light microscopy to monitor successful outcome: As mentioned earlier, within a week after EBV infection, small clusters of cells in the flask are visible by light microscopy (Figure 3B). As time progresses and cells develop into LCL, microscopic clusters become larger (Figure 3C) such that clumps are visible macroscopically in the flask.",
            "cite_spans": [],
            "section": "6. Representative results: ::: Protocol",
            "ref_spans": []
        },
        {
            "text": "Figure 1. Workflow for generation and cryopreservation of lymphoblastoid cell lines. Peripheral blood is centrifuged through a Ficoll gradient. PBMC present in the buffy coat of an established gradient are exposed to FK506 followed by addition of EBV. EBV-exposed cells are grown at 37\u00b0C in the presence of 5% CO2 to establish and subsequently expand LCL for cryopreservation.",
            "cite_spans": [],
            "section": "6. Representative results: ::: Protocol",
            "ref_spans": []
        },
        {
            "text": "Figure 2. Identification of a sub-population of B cells expected to undergo proliferation after exposure to EBV. Un-infected PBMC (A) or PBMC exposed to EBV derived from HH514-16 cells (B) or from B95-8 cells (C) in the presence of FK506 were harvested on day 3. Cells were stained with fluorochrome-conjugated antibodies directed against CD19, CD23, and CD58. After gating on live cells, un-infected (A) and EBV-exposed (B and C) CD19+ B cells were examined for expression of CD23 and CD58. A sub-population of B cells expressing CD58 and high levels of CD23 (CD23hiCD58+), observed only in the cells exposed to transformation competent EBV (derived from B95-8 cells), is depicted.",
            "cite_spans": [],
            "section": "6. Representative results: ::: Protocol",
            "ref_spans": []
        },
        {
            "text": "Figure 3. Visualization of cell clusters in EBV-infected cells. PBMC were treated with FK506 and infected with EBV. Un-infected (A) and EBV-exposed (B) cells were examined one week post-infection by phase contrast microscopy (10X magnification). Five-week old lymphoblastoid cell line is shown in C.",
            "cite_spans": [],
            "section": "6. Representative results: ::: Protocol",
            "ref_spans": []
        },
        {
            "text": "The method described in this paper generates LCL from donor peripheral blood with rapid immortalization and cryopreservation times. Through the use of FK506, a T cell immunosuppressant, and high titers of infectious virus we are able to promote proliferation of EBV-infected B cells from peripheral blood mononuclear cells. These interventions make the described method more efficient, resulting in rapid expansion of cells for subsequent experiments. ",
            "cite_spans": [],
            "section": "Discussion",
            "ref_spans": []
        },
        {
            "text": "Traditionally, growth transformation has been monitored by visualization of clusters of cells by light microscopy about a week after exposure to EBV6, 15. However, clustering of cells is not a specific indicator of EBV-mediated growth transformation. We have previously demonstrated consistent identification of the proliferating cell population via flow cytometry14, providing an accurate and specific method to determine successful outcome as early as three days after exposure of B cells to EBV. ",
            "cite_spans": [],
            "section": "Discussion",
            "ref_spans": []
        },
        {
            "text": "No conflicts of interest declared.",
            "cite_spans": [],
            "section": "Disclosures",
            "ref_spans": []
        }
    ],
    "ref_entries": {},
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Persistence of the Epstein-Barr virus and the origins of associated lymphomas",
            "authors": [
                {
                    "first": "DA",
                    "middle": [],
                    "last": "Thorley-Lawson",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gross",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "N. Engl. J. Med",
            "volume": "350",
            "issn": "",
            "pages": "1328-1337",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Use of spontaneous Epstein-Barr virus lymphoblastoid cell lines genetically modified to express tumor antigen as cancer vaccines: mutated p21 ras oncogene in pancreatic carcinoma as a model",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Kubuschok",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Hum. Gene Ther",
            "volume": "13",
            "issn": "",
            "pages": "815-827",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Human B lymphocytes immortalization by Epstein-Barr virus in the presence of cyclosporin A",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Pelloquin",
                    "suffix": ""
                },
                {
                    "first": "JP",
                    "middle": [],
                    "last": "Lamelin",
                    "suffix": ""
                },
                {
                    "first": "GM",
                    "middle": [],
                    "last": "Lenoir",
                    "suffix": ""
                }
            ],
            "year": 1986,
            "venue": "In Vitro Cell Dev. Biol",
            "volume": "22",
            "issn": "",
            "pages": "689-694",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Epstein-Barr virus transformation of cryopreserved lymphocytes: prolonged experience with technique",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Pressman",
                    "suffix": ""
                },
                {
                    "first": "JI",
                    "middle": [],
                    "last": "Rotter",
                    "suffix": ""
                }
            ],
            "year": 1991,
            "venue": "Am. J. Hum. Genet",
            "volume": "49",
            "issn": "",
            "pages": "467-467",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "Epstein-Barr virus: Transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Miller",
                    "suffix": ""
                }
            ],
            "year": 1972,
            "venue": "Proc. Nat. Acad. Sci",
            "volume": "69",
            "issn": "",
            "pages": "383-387",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "Identification of a sub-population of B cells that proliferates after infection with Epstein-Barr virus",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Megyola",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Ye",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Bhaduri-McIntosh",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Virol. J",
            "volume": "8",
            "issn": "",
            "pages": "84-84",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "Generation of Epstein-Barr virus (EBV)-immortalized B cell lines",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Tosato",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                }
            ],
            "year": 1991,
            "venue": "Current Protocols of Immunology",
            "volume": "Chapter 7",
            "issn": "",
            "pages": "22-22",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "B cells under influence: transformation of B cells by Epstein-Barr virus",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Kuppers",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Nat. Rev. Immunol",
            "volume": "3",
            "issn": "",
            "pages": "801-812",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Traggiai",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Nat. Med",
            "volume": "10",
            "issn": "",
            "pages": "871-875",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Maintenance of serological memory by polyclonal activation of human memory B cells",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Bernasconi",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Traggiai",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Lanzavecchia",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Science",
            "volume": "298",
            "issn": "",
            "pages": "2199-2202",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "An efficient method for the rapid establishment of Epstein-Barr virus immortalization of human B lymphocytes",
            "authors": [
                {
                    "first": "H-M",
                    "middle": [],
                    "last": "Oh",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Cell Prolif",
            "volume": "36",
            "issn": "",
            "pages": "191-197",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "Use of a simple method for the Epstein-Barr virus transformation of lymphocytes from members of large families of Reunion Island",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ventura",
                    "suffix": ""
                }
            ],
            "year": 1988,
            "venue": "Hum. Hered",
            "volume": "38",
            "issn": "",
            "pages": "36-43",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "Efficiency of transformation of lymphocytes by Epstein-Barr virus",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Henderson",
                    "suffix": ""
                }
            ],
            "year": 1977,
            "venue": "Virology",
            "volume": "76",
            "issn": "",
            "pages": "152-163",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "Characteristics of Epstein-Barr virus activation of human B lymphocytes",
            "authors": [
                {
                    "first": "AG",
                    "middle": [],
                    "last": "Bird",
                    "suffix": ""
                }
            ],
            "year": 1981,
            "venue": "J. Exp. Med",
            "volume": "154",
            "issn": "",
            "pages": "832-839",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "A routine method for the establishment of permanent growing lymphoblastoid cell lines",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Neitzel",
                    "suffix": ""
                }
            ],
            "year": 1986,
            "venue": "Hum. Genet",
            "volume": "73",
            "issn": "",
            "pages": "320-326",
            "other_ids": {
                "DOI": []
            }
        }
    }
}